Deuterium Depletion Is the Key to Getting a Breakthrough in Cancer Therapy
HYD LLC announces review papers on Deuterium-Depleted Water (DDW) in cancer therapy, showing DDW inhibits tumor cell proliferation and migration, promotes autophagy, apoptosis, and senescence, and can reduce cancer recurrence. DDW's mechanism involves different isotopic properties of Hydrogen and Deuterium, leading to altered cell division and metabolism. A Phase 2 trial demonstrated DDW's efficacy in reducing prostate cancer size and improving survival rates. HYD seeks partners for Phase II/III studies to potentially approve DDW as a cancer treatment.
Reference News
HYD LLC announces review papers on Deuterium-Depleted Water (DDW) in cancer therapy, showing DDW inhibits tumor cell proliferation and migration, promotes autophagy, apoptosis, and senescence, and can reduce cancer recurrence. DDW's mechanism involves different isotopic properties of Hydrogen and Deuterium, leading to altered cell division and metabolism. A Phase 2 trial demonstrated DDW's efficacy in reducing prostate cancer size and improving survival rates. HYD seeks partners for Phase II/III studies to potentially approve DDW as a cancer treatment.